1/58
Looks like no tags are added yet.
sildenafil
B: viagra; revatio
sildenafil class
PDE5i
sildenafil indication
pulmonary arterial htn
sildenafil dose
20mg po tid
sildenafil adjustments
r and h: no
sildenafil ADR
CV: severe hypotension (m: BP + HR)
tadalafil
B: cialis; adcirca
tadalafil class
PDE5i
tadalafil indication
pulmonary arterial htn
tadalafil dose
40mg po qd
tadalafil adjustments
r: yes and h: no
tadalafil ADR
CV: severe hypotension (m: BP + HR)
epoprostenol
B: flolan; veletri
epoprostenol class
prostacyclin analogue
epoprostenol dose
2ng/kg/min IV then titrate
epoprostenol adjustments
r and h: no
epoprostenol ADR
CV: rebound PAH (m: continuous infusion status)
iloprost
B: ventavis
iloprost class
prostacyclin analogue
iloprost indication
pulmonary arterial htn
iloprost dose
2.5-5mcg inhaled 6-9x/day
iloprost adjustments
r and h: no
iloprost ADR
pulmonary: bronchospasm (m: respiratory status)
treprostinil
B: remodeling; tyvaso
treprostinil class
prostacyclin analogue
treprostinil indication
pulmonary arterial htn
treprostinil dose
18mcg inhaled QID → titrate
treprostinil adjustments
r and h: no
treprostinil ADR
CV: hypotension (m: BP)
riociguat
B: adempas
riociguat class
sGC stimulator
riociguat indication
PAH/ CTEPH
riociguat dose
1mg po TID then titrate
riociguat adjustments
r and h: no
riociguat ADR
hem/immunologic: embryo-fetal toxicity (m: pregnancy test)
selexipag
B: uptravi
selexipag class
IP receptor agonist
selexipag indication
pulmonary arterial htn
selexipag dose
200mcg bid → titrate
selexipag adjutsments
r and h: no
selexipag ADR
CV: hypotension (m: BP)
bosentan
B: tracleer
bosentan class
endothelial receptor antagonist
bosentan indication
pulmonary arterial htn
bosentan dose
6.25mg bid → 125mg bid
bosentan adjustments
r and h: no
bosentan ADR
GI/hepatic: hepatotoxicity (m: monthly LFT’s)
macitentan
B: opsumit
macitentan class
endothelial receptor antagonist
macitentan indication
pulmonary arterial htn
macitentan dose
10mg qd
macitentan adjustments
r and h: no
macitentan ADR
hem/immunologic: anemia (m: hgb)
ambrisentan
B: letaris
ambrisentan class
endothelial receptor antagonist
ambrisentan indication
pulmonary arterial htn
ambrisentan dose
5mg qd → 10mg
ambrisentan adjustments
r and h: no
ambrisentan ADR
GI/hepatic: hepatotoxicity (m: LFTs)